CLINICAL TRIAL / NCT05251363

Inclusion Criteria: * Patient is a candidate for implantation of a BIOTRONIK pacemaker system, per standard guidelines. Single chamber, dual chamber, and Cardiac Resynchronization Therapy with a Pacemaker (CRT-P) systems are allowed. * Patient has an implant planned to utilize left bundle branch area pacing within 30 days of consent * Patient is able to understand the nature of the study and provide written informed consent * Patient is available for follow-up visits on a regular basis for the expected duration of follow-up * Patient accepts Home Monitoring® concept * Patient age is greater than or equal to 18 years at time of consent Exclusion Criteria: * Patient meets a standard contraindication for pacemaker system implant * Patient is currently implanted with a pacemaker or Implantable Cardioverter-Defibrillator (ICD) device * Patient has had a previous unsuccessful attempt to place a lead in the LBB area * Patient has planned cardiac surgical procedures or interventional measures within 3 months after implant * Patient is expected to receive a heart transplant within 12 months * Patient life expectancy less than 12 months * Patient has the presence of another life-threatening, underlying illness separate from their cardiac disorder * Patient reports pregnancy at the time of enrollment * Patient is enrolled in any other investigational cardiac clinical study during the course of the study